期刊
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH
卷 16, 期 -, 页码 S11-S14出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.ijir.3901208
关键词
phosphodiesterase inhibitors; 3 ',5 '-cyclic-nucleotide phosphodiesterase; sildenafil; vardenafil; tadalafil
Phosphodiesterases (PDEs) play a decisive role in cyclic nucleotide-mediated intracellular signaling. As PDEs are expressed in a variety of tissues, selectivity is a prerequisite for a therapeutically applicable PDE inhibitor. Sildenafil, vardenafil, and tadalafil are selective for PDE5, with vardenafil exhibiting the highest potency and minimal inhibition of other PDEs, with the exception of PDE6. Tadalafil is extremely selective for PDE5, but also potently inhibits PDE11, an enzyme with unknown physiological function. As PDE1 is expressed in the brain, myocardium, and vascular smooth muscle cells, nonselectivity with respect to this enzyme ( selectivity: tadalafil > vardenafil > sildenafil) may result in vasodilation and tachycardia. Inhibition of PDE6 ( selectivity: tadalafil > vardenafil congruent to sildenafil), which is expressed only in retina and functions in visual transduction, can transiently disturb vision. PDE5 inhibitors may also indirectly inhibit PDE3 by increasing cyclic guanosine monophospate levels, thereby elevating heart rate and vasodilation while inhibiting platelet aggregation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据